Interleukin-2

Proleukin

Near Add Your Location

Sorting 3 by

Accepting patients

NK Cell Therapy Post-Transplant

Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
  • Natural Killer Cells (Allogeneic)
  • Phase 1

Accepting patients

NK Cells Plus Vactosertib

A Phase Ib Study to Evaluate Safety and Persistence of ex Vivo Expanded Universal Donor NK Cells in Combination With IL-2 and TGFbeta Receptor I Inhibitor Vactosertib in Patients With Locally Advanced/Metastatic Colorectal Cancer, Gastric/Esophageal Cancer, and Relapsed/Refractory Hematologic Malignancies
  • Kinase Inhibitor
  • Natural Killer Cells (Allogeneic)
  • Phase 1

Not yet accepting

Autologous T Cells

A Phase I Study of Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Other Hematologic Malignancies
  • T Cell
  • Phase 1